1. Prescribing Information. Rozerem® (ramelteon) tablets. Takeda Pharmaceuticals, Deerfield, Illinois. October 2008. Available at http://www.rozerem.com/. Accessed July 17, 2010.
2. Neurochemical properties of ramelteon (TAK-357), a selective MT1/MT2 receptor agonist;Kato;Neuropharmacology,2005
3. Ramelteon for insomnia symptoms in a community sample of adults with generalized anxiety disorder: an open label study;Gross;J Clin Sleep Med,2009
4. Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia;Zammit;J Clin Sleep Med,2007
5. Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment;Roth;Pharmacology,2005